Literature DB >> 3510758

Biventricular function during volume loading in porcine E. coli septic shock, with emphasis on right ventricular function.

A J Schneider, G J Teule, A D Kester, G A Heidendal, L G Thijs.   

Abstract

In 14 anesthesized pigs, the effect of E. coli (2 X 10(8)/kg) and volume loading on hemodynamics and right and left ventricular performance were studied. Autologous red cells were labeled in vitro with 99mTC (15-20 mCi). Gated blood pool studies and hemodynamics were performed simultaneously. E. coli infusion resulted in an abrupt increase in pulmonary artery pressure, whereas systemic blood pressure fell gradually. Gated studies showed a transient increase in right ventricular end-diastolic volume (RVEDV) after 1 hour; left ventricular end-diastolic volume (LVEDV) declined gradually during sepsis. During volume loading, RVEDV and LVEDV both increased. As estimated from the altered Frank Starling relation between preload and SW, a depressed performance of both left and right ventricle was found. We conclude that volume expansion in porcine E. coli septic shock results in a uniform increase of left and right preload despite a substantial increase in pulmonary vascular resistance.

Entities:  

Mesh:

Year:  1986        PMID: 3510758

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  3 in total

1.  Escherichia coli sepsis and endotoxemia in conscious young pigs.

Authors:  E Schrauwen; E Cox; A Houvenaghel
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

2.  Inhaled nitric oxide in combination with volume resuscitation refines a porcine model of endotoxic shock.

Authors:  N A Herity; J D Allen; B Silke; A A Adgey
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

3.  Right ventricular dysfunction in patients with septic shock.

Authors:  J F Dhainaut; J J Lanore; J M de Gournay; M F Huyghebaert; F Brunet; D Villemant; J F Monsallier
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.